The Covid pandemic accelerated the development of cancer vaccine

The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast ...

“You discover one thing – and then 10 new questions arise”

COVID-19, diabetes, heart disease, and the impact of dog ownership on humans are just some of multitasker Tove Fall’s areas of research. However, her current fo...

Discover ZEISS ZEN core – now for electron microscopy

Watch the recording of our free webinar.

CAR-T-terapin Carvykti rekommenderas i Sverige – behandling förbereds

Karolinska universitetssjukhuset har för första gången i Sverige inlett förberedelser för att behandla en patient med blodcancerformen multipelt myelom med CAR-...

The International Vaccine Institute’s office in Sweden is expanding

The International Vaccine Institute’s Stockholm office has been open for over a year. During the past year, training programmes and projects have been launched,...

Clean solutions - Handling viscose substances with precision

Paar, is one such solution – and uses electric axes and control systems from Festo.

Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Studie: Uppväxtort kan påverka risk för typ 1-diabetes

Risken att utveckla diabetes typ 1 varierar kraftigt beroende på var i Sverige du har bott som barn, enligt en ny studie från Göteborgs universitet. Resultatet ...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

This is the future location of the new national innovation cluster

Mölndal and Goco Health Innovation City will be the site of a new national innovation cluster for advanced therapies. The business community and the Swedish gov...

Metabolon

Suing the company – for NOT developing a new HIV drug

Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Medicon Village Science Park

Ny forskning: Fettsyra i ögonen återställde syn hos äldre möss

En enkel ögoninjektion med en speciell fettsyra kunde återställa synförmågan hos äldre möss, enligt en ny studie vid University of California. Resultatet väcker...

Sahlgrenska Science Park

Conjugate Planes in Microscopy

Knowledge Article from ZEISS.

Bio-Works

New report: Fewer PhDs in life sciences

A new report from Vinnova suggests that competency returns in the life science sector are declining.

ZEISS Quality Innovation Days

The leading digital event from April 15-19, 2024.

Studie: Biomarkörer förutser hjärt-kärlkomplikationer vid typ 2-diabetes

Epigenetiska biomarkörer kan förutsäga vilka personer med typ 2-diabetes som riskerar att få hjärt-kärlsjukdomar, enligt en ny studie från Lunds universitet.

RegSmart Life Science AB

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...